EdwardLewisLainMDMBA

Dermatology • Austin, TX

Acne & Rosacea, Cosmetic Dermatology, Dermatologic Surgery, Pediatric Dermatology

Fellow of American Academy of Dermatology. Chief Medical Officer, Sanova Dermatology Executive Director, Austin Institute for Clinical Research

Join to view full profile

Dr. Lain is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lain's full profile

Already have an account?

Office
5145 FM 620 N
Ste B-110
Austin, TX 78732
Phone+1 512-266-0007

Fax+1 512-266-0077

Summary

Dr. Edward Lain is a dermatologist in Austin, TX. He received his medical degree from Baylor College of Medicine and has been in practice 15 years. He specializes in acne & rosacea, cosmetic dermatology, dermatologic surgery, and pediatric dermatology and is experienced in dermatologic surgery, cosmetic dermatology, pediatric dermatology, mohs micrographic surgery, and laser resurfacing/fractional laser resurfacing.

Education & Training

University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Dermatology, 2003 - 2006
University of Arkansas for Medical Sciences (UAMS) College of MedicineInternship, Internal Medicine, 2002 - 2003
Rice University Jesse H Jones Graduate School of ManagementMBA, Healthcare Administration, 2000 - 2002
Baylor College of MedicineClass of 2002

Certifications & Licensure

TX State Medical License 2005 - 2026
AR State Medical License 2004 - 2007
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
Fellow (FAAD) American Academy of Dermatology

Clinical Trials

VPD-737 for Treatment of Chronic Pruritus Start of enrollment: 2013 Oct 15
Completed
Phase 2
A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris Start of enrollment: 2014 Aug 01
Completed
Phase 4
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris Start of enrollment: 2015 Apr 01
Completed
Phase 2
A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis Start of enrollment: 2015 Aug 01
Completed
Phase 3
Study of Glycopyrronium in Axillary Hyperhydrosis Start of enrollment: 2015 Jul 01
Completed
Phase 3
Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis Start of enrollment: 2015 Aug 01
Completed
Phase 3
A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Genital Psoriasis Start of enrollment: 2016 Apr 01
Completed
Phase 3
Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis Start of enrollment: 2017 Mar 28
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

Safety and tolerability of tirbanibulin ointment 1% treatment on 100 cmof the face or scalp in patients with actinic keratosis: A phase 3 study.
Neal Bhatia, Edward Lain, Abel Jarell, Janet DuBois, Maria Luisa Tamarit
JAAD International. 2024-12-01
Improving Neck and Jawline Aesthetics With OnabotulinumtoxinA by Minimizing Platysma Muscle Contraction Effects: Efficacy and Safety Results in a Phase 3 Randomized, P...
Sachin M Shridharani, Patricia Ogilvie, Megan Couvillion, Tatjana Pavicic, Edward Lain
Aesthetic Surgery Journal. 2024-10-30
Efficacy of Brodalumab in Patients with Psoriasis and Risk Factors for Treatment Failure: A Review of Post Hoc Analyses.
Mark G Lebwohl, April W Armstrong, Andrew F Alexis, Edward L Lain, Abby A Jacobson
Dermatology and Therapy. 2024-10-01

Lectures

Late-breaking Research: Clinical Trials
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/2/2019

Press Mentions

Athenex Announces Positive Topline Results from Two Phase III Studies of KX2-391 Ointment 1% Featured in Late Breaker Program at the 2019 American Academy of Dermatology Annual MeetingMarch 4th, 2019
Galderma Announces Positive Results from the “CoMMPlete” Regimen Study Including Epiduo® Gel in the Management of Acne in Adolescent Student AthletesMay 24th, 2016

Professional Memberships

American Academy of Dermatology - AAD
Fellow
Texas Medical Association - TMA
Member
American Society for Dermatologic Surgery - ASDS
Member
Alpha Omega Alpha Honor Medical Society - AOA
Fellow

External Links

Dr Ted Lain Dermatologyhttp://www.atxderm.com